OOIR: Observatory of International Research

Papers

(The H4-Index of Cancer Imaging is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Survival impact of a KEAP1-NFE2L2 radiomics model in PDL1 ≥ 50% non-small cell lung cancer treated with pembrolizumab: the PEMBROMIC study	95
Contrast-enhanced ultrasound quantitative parameters for predicting benign and malignant greater omentum lesions: an applied study	85
Prediction of lateral lymph node metastasis with short diameter less than 8 mm in papillary thyroid carcinoma based on radiomics	80
Whole-tumoral metabolic heterogeneity in 18F-FDG PET/CT is a novel prognostic marker for neuroblastoma	67
Predicting malignant risk of ground-glass nodules using convolutional neural networks based on dual-time-point 18F-FDG PET/CT	48
A whole-body diffusion MRI normal atlas: development, evaluation and initial use	48
Ultrasound-guided percutaneous core biopsy of renal sinus masses: diagnostic yield, safety, and clinical impact	46
Intravoxel incoherent motion imaging combined with diffusion kurtosis imaging to assess the response to radiotherapy in a rabbit VX2 malignant bone tumor model	38
Predicting first-line VEGFR-TKI resistance and survival in metastatic clear cell renal cell carcinoma using a clinical-radiomic nomogram	35
Targeted sequencing of DNA/RNA combined with radiomics predicts lymph node metastasis of papillary thyroid carcinoma	34
Optimisation of low and ultra-low dose scanning protocols for ultra-extended field of view PET in a real-world clinical setting	32
Comparison of the diagnostic accuracy of enhanced-CT and double contrast-enhanced ultrasound for preoperative T-staging of gastric cancer: a meta-analysis	30
Clinical application of machine learning models in patients with prostate cancer before prostatectomy	30
Multi-center evaluation of machine learning-based radiomic model in predicting disease free survival and adjuvant chemotherapy benefit in stage II colorectal cancer patients	29
Systematic effects of patient factors and scanner/protocol factors on a Restriction Spectrum Imaging (RSI) quantitative MRI biomarker for prostate cancer	29
A deep learning model to enhance the classification of primary bone tumors based on incomplete multimodal images in X-ray, CT, and MRI	29
Application Value of a nomogram integrating contrast-enhanced CT radiomics and clinical indicators in evaluating lymph node metastasis in pediatric peripheral neuroblastoma	28
An MRI-based radiomics nomogram for differentiating spinal metastases from multiple myeloma	28
The prognostic significance of semi-quantitative metabolic parameters and tumoral metabolic activity based on 123I-MIBG SPECT/CT in pretreatment neuroblastoma patients	28
Preoperative low-attenuation area on computed tomography is associated with recurrence after curative resection for non-small-cell lung cancer	28
Evaluation of 3D ARFI imaging of prostate cancer: diagnostic reliability and concordance with MpMRI	27
Response assessment in rectal cancer undergoing total neoadjuvant therapy: decision tree analysis integrating contrast enhanced T1-weighted MRI	27
Semiautomated pelvic lymph node treatment response evaluation for patients with advanced prostate cancer: based on MET-RADS-P guidelines	27
Parameter-driven habitat imaging based on intravoxel incoherent motion MRI for preoperative prediction of muscle invasion in bladder cancer	27
The CT colonography radiology and data system: history, updates, and future directions	25

Diagnostic performance and prognostic value of preoperative 18F-FDG PET/CT in renal cell carcinoma patients with venous tumor thrombus